ENTITY
Guangzhou Wondfo Biotech C-A

Guangzhou Wondfo Biotech C-A (300482 CH)

22
Analysis
Health CareChina
Guangzhou Wondfo Biotech Co.,Ltd. was founded in 1992. The company's line of business includes manufacturing of medical diagnostic tests. Guangzhou Wondfo Biotech serves customers around the world.
more
18 Aug 2024 10:59

China Healthcare Weekly (Aug.18)- COVID Is Here, BIOSECURE Act Update, Livzon Deserves More Patience

COVID is coming again. So investors can focus on related stocks. US companies leaving Chinese partners due to BIOSECURE Act. Livzon is still worth...

Logo
284 Views
Share
03 Dec 2023 09:29

China Healthcare Weekly (Dec.1) - Medical Device VBP, Biotech to Breakeven Soon, Orient Gene Biotech

VBP result for intraocular lens/sports medicine consumables is better than expected.There’s a chance to see Chinese Biotech turn loss into profits...

Logo
458 Views
Share
11 Sep 2023 07:00

CSI500 Index Rebalance Preview: ETF Inflows Lead to Performance Skew

There should be 50 changes in Dec with a big sector skew. Turnover is ~10% and 31 stocks will have 1x ADV to trade. Huge ETF inflows have led to...

Logo
603 Views
Share
05 Jul 2023 08:55

Guangzhou Wondfo Biotech (300482.CH) - Time to Bottom Fish?

Overall revenue growth would inevitably slow down in 2023, but Wondfo's non-COVID business recovered well in 23Q1, which shows us the momentum to...

Logo
339 Views
Share
04 Jul 2023 05:40

CSI500 Index Rebalance Preview: Potential Adds Outperforming Potential Deletes

We see 50 changes a side for the CSI500 in Dec. The Industrials sector could take a lot of index spots from Materials as one-way turnover exceeds...

Logo
517 Views
Share
x